On this episode of Reporting Norms, host Norm sits down with Jacob Safarik, the CFO of both Optimi Health Corp. and BC Greens Pharmaceutical Inc.—two pioneering companies at the forefront of the cannabis and psychedelic medicine industries. With a background that spans international project finance, entrepreneurship, and regulatory compliance, Jacob shares his unique journey from a blue-collar upbringing in a family business to becoming a leader in GMP-certified pharmaceutical manufacturing. 

Together, they discuss the evolution of medical cannabis and psychedelics, regulatory hurdles, the importance of real-world evidence, and how family business values fuel innovation. Plus, Jacob offers a transparent look at the financial challenges of inventory management and fair value accounting in dynamic, fast-evolving markets, and talks about the road ahead as global attitudes toward alternative medicines continue to shift. 

Whether you’re fascinated by the business side of pharmaceuticals or curious about the future of psychedelic therapy, this conversation offers an insider’s perspective you won’t want to miss

Visit Highiq.ai